• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克服细菌抗生素耐药性的分子策略。

Molecular strategies for overcoming antibiotic resistance in bacteria.

作者信息

Tan Y T, Tillett D J, McKay I A

机构信息

Department of Dermatology, St Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, Centre for Cutaneous Research, 2 Newark Street, London, UK E1 2AT.

出版信息

Mol Med Today. 2000 Aug;6(8):309-14. doi: 10.1016/s1357-4310(00)01739-1.

DOI:10.1016/s1357-4310(00)01739-1
PMID:10904248
Abstract

Overuse of antibiotics in humans and livestock has led to the rapid evolution of bacteria that are resistant to multiple drugs such that even vancomycin, the drug of last resort, is no longer effective against some strains. Apart from the discovery and exploitation of the natural peptide antimicrobial agents that form part of the innate immune systems of plants and animals, there have been few new antibiotics developed in recent years. Here we review strategies designed to exploit recent advances in molecular biology, including recombinant DNA technology, molecular modelling and genomics to develop new antibacterial agents that overcome antibiotic resistance.

摘要

人类和牲畜中抗生素的过度使用导致了对多种药物具有抗性的细菌迅速进化,以至于即使是作为最后手段的万古霉素,对某些菌株也不再有效。除了发现和利用构成动植物先天免疫系统一部分的天然肽抗菌剂外,近年来开发的新抗生素很少。在这里,我们回顾旨在利用分子生物学最新进展的策略,包括重组DNA技术、分子建模和基因组学,以开发克服抗生素耐药性的新型抗菌剂。

相似文献

1
Molecular strategies for overcoming antibiotic resistance in bacteria.克服细菌抗生素耐药性的分子策略。
Mol Med Today. 2000 Aug;6(8):309-14. doi: 10.1016/s1357-4310(00)01739-1.
2
Antibiotrophs: The complexity of antibiotic-subsisting and antibiotic-resistant microorganisms.抗生素营养生物:依赖抗生素生存及具有抗生素抗性的微生物的复杂性。
Crit Rev Microbiol. 2016;42(1):17-30. doi: 10.3109/1040841X.2013.875982. Epub 2014 Feb 4.
3
Defensins: The natural peptide antibiotic.防御素:天然肽类抗生素。
Adv Drug Deliv Rev. 2021 Dec;179:114008. doi: 10.1016/j.addr.2021.114008. Epub 2021 Oct 18.
4
Potential Treatment Options in a Post-antibiotic Era.后抗生素时代的潜在治疗选择。
Adv Exp Med Biol. 2018;1052:51-61. doi: 10.1007/978-981-10-7572-8_5.
5
Reprogrammable microbial cell-based therapeutics against antibiotic-resistant bacteria.可编程微生物细胞疗法对抗抗生素耐药菌。
Drug Resist Updat. 2016 Jul;27:59-71. doi: 10.1016/j.drup.2016.06.002. Epub 2016 Jun 22.
6
What if there were no new antibiotics? A look at alternatives.如果没有新的抗生素会怎样?探索替代方案。
Expert Rev Clin Pharmacol. 2016 Dec;9(12):1547-1555. doi: 10.1080/17512433.2016.1241141. Epub 2016 Oct 6.
7
Plants as sources of new antimicrobials and resistance-modifying agents.植物作为新型抗菌药物和耐药修饰剂的来源。
Nat Prod Rep. 2012 Sep;29(9):1007-21. doi: 10.1039/c2np20035j. Epub 2012 Jul 12.
8
Cationic peptides: a new source of antibiotics.阳离子肽:抗生素的新来源。
Trends Biotechnol. 1998 Feb;16(2):82-8. doi: 10.1016/s0167-7799(97)01156-6.
9
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.噬菌体疗法:抗生素耐药危机的潜在解决方案。
J Infect Dev Ctries. 2014 Feb 13;8(2):129-36. doi: 10.3855/jidc.3573.
10
Herbal medicine: the magic way crouching microbial resistance.草药:蹲伏微生物耐药的神奇之道。
Nat Prod Res. 2023 Nov-Dec;37(24):4280-4289. doi: 10.1080/14786419.2023.2172009. Epub 2023 Jan 31.

引用本文的文献

1
Nanoparticles in liposomes: a platform for increased antibiotic selectivity in multidrug resistant bacteria in respiratory tract infections.脂质体中的纳米颗粒:一种提高呼吸道感染多重耐药菌抗生素选择性的平台。
Drug Deliv Transl Res. 2025 Apr;15(4):1193-1209. doi: 10.1007/s13346-024-01662-2. Epub 2024 Jul 24.
2
Inhibitors of pantothenate synthetase of - a medicinal chemist perspective.泛酸合成酶抑制剂——药物化学家的视角
RSC Adv. 2020 Oct 7;10(61):37098-37115. doi: 10.1039/d0ra07398a.
3
A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model.
在一种小鼠皮肤感染模型中,硫肽类细菌素微球菌素 P1 与利福平对耐甲氧西林金黄色葡萄球菌(MRSA)表现出强烈协同作用。
Front Immunol. 2021 Jul 2;12:676534. doi: 10.3389/fimmu.2021.676534. eCollection 2021.
4
Microbial Competition of Rhodotorula mucilaginosa UANL-001L and E. coli increase biosynthesis of Non-Toxic Exopolysaccharide with Applications as a Wide-Spectrum Antimicrobial.粘红酵母 UANL-001L 和大肠杆菌的微生物竞争增加了非毒性胞外多糖的生物合成,可作为广谱抗菌剂应用。
Sci Rep. 2018 Jan 15;8(1):798. doi: 10.1038/s41598-017-17908-8.
5
Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network.基于蛋白质-蛋白质相互作用网络的最大流方法对结核分枝杆菌H37Rv潜在药物靶点进行优先级排序
Clin Transl Med. 2015 Dec;4(1):61. doi: 10.1186/s40169-015-0061-6. Epub 2015 Jun 5.
6
The use of platensimycin and platencin to fight antibiotic resistance.使用扁枝衣霉素和扁枝衣菌素对抗抗生素耐药性。
Infect Drug Resist. 2013 Sep 18;6:99-114. doi: 10.2147/IDR.S25076.
7
Multivalent dendritic molecules as broad spectrum bacteria agglutination agents.多价树状分子作为广谱细菌凝集剂。
Theranostics. 2013 Aug 10;3(9):658-66. doi: 10.7150/thno.6811. eCollection 2013.
8
Identifying co-targets to fight drug resistance based on a random walk model.基于随机游走模型识别抗药共同靶点。
BMC Syst Biol. 2012 Jan 19;6:5. doi: 10.1186/1752-0509-6-5.
9
Therapeutic opportunities of small interfering RNA.小分子干扰RNA的治疗机会
Fundam Clin Pharmacol. 2009 Aug;23(4):367-86. doi: 10.1111/j.1472-8206.2009.00694.x.
10
Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.结核分枝杆菌相互作用组分析揭示了耐药性的潜在途径。
BMC Microbiol. 2008 Dec 23;8:234. doi: 10.1186/1471-2180-8-234.